Market Overview:
The global pharmaceutical grade fish oil market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for pharmaceutical grade fish oils from various applications such as clinical nutrition food, dietary supplements, and others. Pharmaceutical grade fish oils are also used in animal feed and aquaculture industries. North America is expected to dominate the global pharmaceutical grade fish oil market during the forecast period owing to the presence of major players in this region and rising demand for healthy food products.
Product Definition:
Pharmaceutical grade fish oil is a purified, concentrated form of fish oil that has been certified by a regulatory agency as meeting the highest quality and purity standards. It is used as a dietary supplement to provide omega-3 fatty acids important for human health.
Salmon and Trout:
Salmon and trout are two different types of fish that are commonly used in the manufacturing of pharmaceutical grade fish oil. The primary difference between them is their size. While salmon can be used for direct human consumption, it's too large to be utilized in industrial applications. On the other hand, small species such as trout can be utilized directly for human consumption but not in industrial applications due to low oil content and high moisture levels within them.
Marine Fish:
Marine fish and its by-products are used in the manufacturing of pharmaceutical grade fish oil. Marine fish oil is extracted from oily fishes such as anchovy, mackerel, sardine, capelin and eel through mechanical or chemical methods. The method used to extract marine oils depends on the type of raw material being processed.
Application Insights:
The others application segment accounted for the largest revenue share in 2017 and is anticipated to witness significant growth over the forecast period. The segment includes cosmetic products, pet food, and animal feed. Increasing use of pharmaceutical grade fish oil in manufacturing pet foods on account of benefits such as improved health condition along with coat & skin improvement is expected to drive demand over the forecast period.
Increasing awareness regarding cardiovascular diseases among people especially those who are above 50 years of age is expected to fuel product demand from clinical nutrition food applications over the forecast period. In addition, growing usage of clinical nutrition supplements by athletes as well as gym professionals owing to benefits such as increased lean muscle mass along with strength & stamina improvement will further propel industry growth during the study period.
Dietary supplements are widely used for various health conditions ranging from joint pain and heart disease prevention to weight loss management and brain function enhancement owing to their high nutritional content which makes them a better alternative than conventional medicines taken from natural sources.
Regional Analysis:
Asia Pacific accounted for the largest revenue share in 2017. The region is expected to maintain its dominance over the forecast period owing to high product demand from China and India. Rising awareness regarding cardiovascular health, growing geriatric population, and increasing disposable income are some of the major factors driving growth in these countries. In addition, rising consumption of processed food along with expanding retail market is projected to further fuel industry expansion over the next eight years.
Europe was valued at USD X billion in 2017 and is anticipated to witness significant growth during the forecast period on account of rising consumer awareness regarding fish oil benefits coupled with growing health concerns pertaining towards dietary supplements products including fish oil capsules/tablets).
North America also held a considerable share owing to presence of key manufacturers such as Pfizer Inc., GSK Holdings plc., Merck & Co.
Growth Factors:
- Increasing demand for pharmaceutical grade fish oil due to its health benefits is expected to drive the market growth.
- Rising awareness about the health benefits of consuming pharmaceutical grade fish oil is anticipated to fuel the market growth.
- Growing use of pharmaceutical grade fish oil in nutraceuticals and functional foods is projected to boost the market growth over the forecast period.
- Increasing research and development activities for new applications of pharmaceutical grade fish oil is likely to propel the market expansion during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Grade Fish Oil Market Research Report
By Type
Salmon and Trout, Marine Fish, Carps, Tilapias, Others
By Application
Clinical Nutrition Food, Dietary Supplements, Others
By Companies
Stepan Specialty Products, Nordic Naturals, OLVEA Fish Oils, Omega Protein, Kobyalar Group, Austevoll Seafood
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Grade Fish Oil Market Report Segments:
The global Pharmaceutical Grade Fish Oil market is segmented on the basis of:
Types
Salmon and Trout, Marine Fish, Carps, Tilapias, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Nutrition Food, Dietary Supplements, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stepan Specialty Products
- Nordic Naturals
- OLVEA Fish Oils
- Omega Protein
- Kobyalar Group
- Austevoll Seafood
Highlights of The Pharmaceutical Grade Fish Oil Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Salmon and Trout
- Marine Fish
- Carps
- Tilapias
- Others
- By Application:
- Clinical Nutrition Food
- Dietary Supplements
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Grade Fish Oil Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical grade fish oil is a purified form of omega-3 fatty acids that has been processed to meet the highest standards for quality and purity. It is typically derived from cold-water fish, such as salmon or tuna, and has been tested to ensure that it contains the correct levels of EPA and DHA.
Some of the major players in the pharmaceutical grade fish oil market are Stepan Specialty Products, Nordic Naturals, OLVEA Fish Oils, Omega Protein, Kobyalar Group, Austevoll Seafood.
The pharmaceutical grade fish oil market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Grade Fish Oil Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharmaceutical Grade Fish Oil Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharmaceutical Grade Fish Oil Market - Supply Chain
4.5. Global Pharmaceutical Grade Fish Oil Market Forecast
4.5.1. Pharmaceutical Grade Fish Oil Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharmaceutical Grade Fish Oil Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pharmaceutical Grade Fish Oil Market Absolute $ Opportunity
5. Global Pharmaceutical Grade Fish Oil Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Type
5.3.1. Salmon and Trout
5.3.2. Marine Fish
5.3.3. Carps
5.3.4. Tilapias
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pharmaceutical Grade Fish Oil Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Application
6.3.1. Clinical Nutrition Food
6.3.2. Dietary Supplements
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pharmaceutical Grade Fish Oil Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pharmaceutical Grade Fish Oil Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pharmaceutical Grade Fish Oil Demand Share Forecast, 2019-2026
9. North America Pharmaceutical Grade Fish Oil Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Application
9.4.1. Clinical Nutrition Food
9.4.2. Dietary Supplements
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Type
9.7.1. Salmon and Trout
9.7.2. Marine Fish
9.7.3. Carps
9.7.4. Tilapias
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pharmaceutical Grade Fish Oil Demand Share Forecast, 2019-2026
10. Latin America Pharmaceutical Grade Fish Oil Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Application
10.4.1. Clinical Nutrition Food
10.4.2. Dietary Supplements
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Type
10.7.1. Salmon and Trout
10.7.2. Marine Fish
10.7.3. Carps
10.7.4. Tilapias
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pharmaceutical Grade Fish Oil Demand Share Forecast, 2019-2026
11. Europe Pharmaceutical Grade Fish Oil Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Application
11.4.1. Clinical Nutrition Food
11.4.2. Dietary Supplements
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Type
11.7.1. Salmon and Trout
11.7.2. Marine Fish
11.7.3. Carps
117.4. Tilapias
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pharmaceutical Grade Fish Oil Demand Share, 2019-2026
12. Asia Pacific Pharmaceutical Grade Fish Oil Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Application
12.4.1. Clinical Nutrition Food
12.4.2. Dietary Supplements
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Type
12.7.1. Salmon and Trout
12.7.2. Marine Fish
12.7.3. Carps
12.7.4. Tilapias
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pharmaceutical Grade Fish Oil Demand Share, 2019-2026
13. Middle East & Africa Pharmaceutical Grade Fish Oil Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Application
13.4.1. Clinical Nutrition Food
13.4.2. Dietary Supplements
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pharmaceutical Grade Fish Oil Market Size and Volume Forecast by Type
13.7.1. Salmon and Trout
13.7.2. Marine Fish
13.7.3. Carps
13.7.4. Tilapias
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pharmaceutical Grade Fish Oil Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pharmaceutical Grade Fish Oil Market: Market Share Analysis
14.2. Pharmaceutical Grade Fish Oil Distributors and Customers
14.3. Pharmaceutical Grade Fish Oil Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Stepan Specialty Products
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Nordic Naturals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. OLVEA Fish Oils
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Omega Protein
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Kobyalar Group
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Austevoll Seafood
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook